|
血栓性血小板减少性紫癜 溶血性尿毒症综合征的研究进展 |
| |
J].N Engl J Med，1982，307:14321435.
[8] FURLAN M, ROBLES R,LAMMLE B. Partial purification and characterization of a protease from human plasma cleaving von Willebrand fator to fragments produced by in vivo proteolysis[J].Blood，1996，7:42234234.
[9] TSAI HM.Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion[J].Blood，1996，87:42354244.
[10] LEVY GG, NICHOLS WC,LIAN EC,et al.Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura[J].Nture，2001，413:488494.
[11] PLAIMAUER B,SCHEIFLINGER F.Expression and characterization of recombinant human ADAMTS13[J].Semin Hematol，2004，41:2433.
[12] PLAIMAUER B, ZIMMERMANN K, VOLKEL D,A et al.Cloning, expression, and functional characterization of the von Willebrand factorcleaving protease(ADAMTS13) [J].Blood，2002，100: 36263632.
[13] SUZUKI M,MURATA M,MATSUBARA Y, et al. Detection of von Willebrand factor cleaving protease in human platelets[J]. Biochem Biophys Res Commun， 2004，313:212216.
[14] SCHNEPPENHEIM R, BUDDE U, OYEN F, et al. Von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP[J].Blood，2003，101：18451850.
[15] ZHENG X， NISHIO&上一页 [1] [2] [3] [4] [5] [6] 下一页
上一个医学论文： 人凝血因子 基因多态性与血栓性疾病
下一个医学论文： 炎症与高血压
|
|
|
|
|
|
|
您现在的位置： 绿色健康网 >> 医学论文 >> 内科论文 >> 正文